The D- Coded Directory

Decoded is the answer to a simple question – Why should one’s limited understanding of medical terminology, tech specs and research methodology come in the way of learning about their condition. Browse through our journal to get up to speed on all the latest and greatest in T1D research.

An unwelcome inheritance: childhood obesity after diabetes in pregnancy

BMI
Insulin Resistance
Obesity
Hyperglycemia

Stem cells differentiation into insulin-producing cells (IPCs): recent advances and current challenges

IPCs
Stem Cells
Cell Therapy
Type 1 diabetes (T1D)

The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis

COVID 19
PRISMA
SARS-CoV2
CI
Diabetes
Type 1 diabetes (T1D)

Investigating the efficacy of baricitinib in new onset type 1 diabetes mellitus (BANDIT)—study protocol for a phase 2, randomized, placebo-controlled trial.

C-peptide
Baricitinib
JAK
Monoclonal Antibodies
Type 1 diabetes (T1D)

Understanding the article: “The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview”

Severe hypoglycemia
Myocardial infarction
Retinopathy
Cardiovascular disease (CVD)
Diabetes
Type 1 diabetes (T1D)

Vertex Presents Positive VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes.

Vertex
Efficacy
Endogenous
Immunosuppressive therapy
Hepatic portal vein
SHEs

Continuous Glucose Monitoring in pregnant women with type 1 diabetes CONCEPTT: a multicenter international randomized controlled trial.

CGM
Time in Range (TIR)
Intensive Insulin therapy
Glycemic Control
Pre-Eclampsia
Congenital Anomaly

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes.

Trial Net
Clinical trial
Autoantibodies
Auto Immune system
Glucose tolerance test
Placebo
  • All Posts
  • Blog